The Public Readiness and Emergency Preparedness Act lets pharmacists prescribe coronavirus treatments, but the emergency use authorizations for two antivirals exclude pharmacists, so pharmacists are urging FDA to revise those EUAs. Pharmacy groups also are urging CMS to revise guidance to require that insurers pay pharmacists for services related to prescribing and dispensing coronavirus therapies. “The federal government has already authorized pharmacists to order and dispense oral therapeutics under the PREP Act,” according to a statement by several pharmacy organizations...